GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Affymax, Inc. (AFFY) [hlAlert]

Affymax, Inc. is a biopharmaceutical company developing peptide-based drugs to improve the treatment of serious and often life-threatening conditions. The Company's product candidate, Hematide, is designed to treat anemia associated with chronic renal failure.
Hematide is a relatively small synthetic peptide-based erythropoiesis stimulating agent (ESA), which it is developing for the treatment of anemia patients with chronic renal failure. The Company is conducting Phase III clinical trials in patients suffering from chronic renal renal failure, on dialysis and not on dialysis (pre-dialysis). In August 2008, the Company and Takeda Pharmaceutical Company Limited (Takeda), agreed to suspend development of Hematide to treat chemotherapy induced anemia.
.
( Total: 13 Current Stock Recommendations )
Affymax, Inc.   (13)
Sell Hold 46% Buy 46%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
2/26/2013  
Hold
  
3/19/2013  
Sell
  
11/23/2010  
Buy
  
9/18/2013  
Hold
  
3/11/2011  
Buy
  
10/4/2010  
Buy
  
9/24/2008  
Buy
  
3/14/2008  
Buy
  
7/30/2008  
Hold
  
2/25/2013  
Hold
  
2/25/2013  
Hold
  
2/25/2013  
Hold
  
2/8/2013  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy